Process Control, Automation, and PAT

Automation Downstream Controls Quality

August 21, 2024

Downstream processes may be streamlined by using automation.

Streamlining Bioprocesses with Automation

August 09, 2024

Automation technologies used in the development and manufacture of biopharmaceuticals continue to evolve, providing the potential for reduced costs and time.

Speeding Up Aseptic Processes

June 13, 2024

Technological advances are aiding manufacturers to streamline aseptic processes and improve time-to-market.

Industry Tackles Automating and Standardizing CGT Manufacturing Processes (BIO 2024)

June 08, 2024

CGT manufacturing processes need automation as well as standardization, according to Lonza’s Joe Garrity and Jerry Jiang.

BIO 2024: Characterizing and Engineering Molecules with AI

June 07, 2024

Raphael Townshend, founder and CEO of Atomic AI, speaks on AI’s usefulness in characterizing molecular structure and advancing molecular engineering.

Exploring How Chemistry, Robotics, and AI are Advancing Drug Discovery (BIO 2024)

June 06, 2024

Chemify founder and CEO, Lee Cronin gives insight into the combination of digital chemistry, robotics, and AI in the drug discovery process.

Publisher's Note: Automating Processes

June 03, 2024

Improved efficiencies and reduced costs are clear advantages of automating drug manufacturing processes.

Cellular Origins Partners with CGT Catapult on Automated CGT Manufacturing

May 31, 2024

Cellular Origins will apply its robotic platform to establish automated CGT manufacturing at CGT Catapult’s manufacturing innovation center in Stevenage, UK.

Shoring Up Data Integrity Practices

May 05, 2024

Digital transformation is allowing for better handling, analysis, and protection of vast data collection.

Bristol Myers Squibb and Cellares Enter Into $380 Million Agreement for Technology to Manufacture CAR-T Cell Therapies

April 23, 2024

Under the agreement, Bristol Myers Squibb will have access to Cellares’ fully automated cell therapy manufacturing platform, Cell Shuttle, to manufacture select CAR-T cell therapies.